Actively Recruiting

Phase 4
Age: 19Years +
All Genders
Healthy Volunteers
ID05967117

Chest CT Using Low-concentration Iodine Contrast Media - a Prospective Multicenter Comparative Study

Led by Jung Im Jung · Updated on 2024-07-25

370

Participants Needed

6

Research Sites

N/A

Total Duration

On this page

Sponsors

J

Jung Im Jung

Lead Sponsor

T

Taejoon Pharmaceutical Co., Ltd.

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the quality of chest CT images using different concentrations of iodine contrast agents combined with varying tube voltages. The study aims to determine whether low-concentration iodine contrast media with low tube voltage can produce images suitable for routine chest CT scans. This research focuses on optimizing chest CT protocols and improving image quality while potentially reducing contrast agent concentration. Participants will receive one of four chest CT scan protocols: conventional iodine contrast with conventional tube voltage, conventional iodine contrast with low tube voltage, low-concentration iodine contrast with low tube voltage, or ultra-low-concentration iodine contrast with low tube voltage. The iodine contrast media used are different concentrations of Iohexol, administered intravenously with a 100 mL injection followed by saline flushing, and CT images are captured 55 seconds after injection. During the study, participants will undergo a contrast-enhanced chest CT scan following the assigned protocol. Researchers will evaluate image quality aspects such as anatomic depiction, noise, contrast-related artifacts, and overall diagnostic acceptability. These assessments will be done up to 12 months after the CT scan. The study involves a randomized and double-blind design, and participants will be monitored to optimize chest CT imaging protocols using iodine contrast agents.

CONDITIONS

Brief Title

Chest CT Using Low-concentration Iodine Contrast Media

Who Can Participate

Age: 19Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 19 years or older
  • Weigh less than 90 kg
  • Have a body mass index (BMI) less than 30
  • Undergoing contrast-enhanced chest CT scan alone
  • Able to voluntarily provide written consent to participate
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Unable to undergo contrast-enhanced CT
  • Have heart failure
  • Are pregnant
  • Have anatomical deformation interfering with image analysis
  • History of hypersensitivity to IOBRIX, its components, or iodine-based drugs
  • Have severe thyroid disease
  • Judged unsuitable by the tester for other reasons related to safety or study participation suitability
  • Unable to provide voluntary written consent to participate in this clinical trial if required by the study protocol or investigator judgment based on source text repetition of consent requirement

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 1 day

Participants undergo a chest contrast-enhanced CT scan using one of the specified iodine contrast media and tube voltage protocols.

1 visit (in-person)

Follow-up

Duration - 12 months

Participants' CT images are evaluated for image quality, noise, artifact, and diagnostic acceptability up to 12 months after the CT scan.

Assessments done remotely; no additional visits required

Trial Site Locations

Total: 6 locations

1

Bucheon St. Mary's Hospital, The Catholic University of Korea

Bucheon-si, Gyeonggi-do, South Korea, 14647

Completed

2

Pusan National University Yangsan Hospital

Yangsan, Gyeongsangnam-do, South Korea, 50612

Actively Recruiting

3

Jeonbuk National University Hospital

Jeonju, Jeollabuk-do, South Korea, 54907

Actively Recruiting

4

Seoul St. Mary's Hospital, The Catholic University of Korea

Seoul, Seocho-gu, South Korea, 06591

Actively Recruiting

5

Chonnam National University Hospital

Gwangju, South Korea, 61469

Completed

6

Seoul National University Hospital

Seoul, South Korea, 03080

Completed

Loading map...

Research Team

J

Jung IM Jung, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

4

Similar Trials

Advanced Imaging Holistic Omics Biobank Observational Study ...

Oncologic Disorders

Actively Recruiting

1 location

WARD Prospective Study - Continuous Wireless Monitoring of V...

Surgical Complication

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here